ArticleThe journal of vascular access2026
Selection of central versus peripheral vascular access in patients receiving chemotherapy: A survey among Italian nurses promoted by the Italian Lymphoma Foundation.
Article in The journal of vascular access, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectivesCentral venous catheters are recommended for chemotherapy administration, but peripheral intravenous catheters are frequently used. This study examined venous access practices (central vs peripheral) for administering antineoplastic agents to patients with solid or hematologic malignancies and assessed the associated educational aspects. DESIGN, SETTING, AND
participantsA questionnaire developed according to the Enhancing the Quality and Transparency of Health Research Guidelines was distributed to Italian hematology/oncology nurses who performed intravenous chemotherapy administration and peripheral vein cannulation. Of 171 questionnaires returned, 141 were completed.
resultsStatistics showed that 33% of respondents used peripheral veins for at least 25% of patients within 30-day period. Peripheral veins were chosen because of organizational challenges, urgency, and central catheter issues or malfunctions. Irritant and vesicant drugs were administered by 60% and 49.3% of respondents. The study found 81.7% of nurses received additional education on chemotherapy administration. While 95.8% of nurses informed patients about chemotherapy side effects and extravasation signs, 77.5% did not document this in patients' charts. Informed consent forms often lacked specifications for peripheral vein administration (63.9%), essential for safe antineoplastic agent administration.
conclusionsThe survey highlighted the need for standardized guidelines for intravenous chemotherapy, as peripheral veins serve multiple purposes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.